Michael Bogart

4PUBLICATIONS
14CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Clinical chemistry (incl. diagnostics)Pharmaceutical delivery technologiesOtorhinolaryngology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Nov 07, 2023
Changes in Oral Corticosteroid Utilization in Patients with COPD Following Initiation of FF/UMEC/VI.

Michael Bogart, Carl B Abbott, Mohan Bangalore

|Mar 31, 2023
COPD Exacerbations, Costs, and Health Care Resource Utilization Before and After Initiation of Fluticasone Furoate/Umeclidinium/Vilanterol in Routine Care in the USA.

Nicola A Hanania, Scott H Bunner, Lindsay G S Bengtson

|Mar 14, 2022
Benefit of Prompt versus Delayed Use of Single-Inhaler Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Following a COPD Exacerbation.

David Mannino, Michael Bogart, Guillaume Germain

Pageof 1